D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ANIP holding history
Ani Pharmaceuticals Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ANIP overviewAll 13F holders of ANIPFull Q2 2026 holdings
- Shares (Q2 2026)
- 174,732
- Value
- $14.5M
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 174,732 | $14.5M | <0.1% | −38,701−18.1% | Reduced | Holders |
| Q1 2026 | 213,433 | $16.4M | <0.1% | −40,103−15.8% | Reduced | Holders |
| Q4 2025 | 253,536 | $20.0M | <0.1% | +40,530+19.0% | Added | Holders |
| Q3 2025 | 213,006 | $19.5M | <0.1% | +144,714+211.9% | Added | Holders |
| Q2 2025 | 68,292 | $4.46M | <0.1% | −161,409−70.3% | Reduced | Holders |
| Q1 2025 | 229,701 | $15.4M | <0.1% | +33,382+17.0% | Added | Holders |
| Q4 2024 | 196,319 | $10.9M | <0.1% | +87,698+80.7% | Added | Holders |
| Q3 2024 | 108,621 | $6.48M | <0.1% | +99,861+1,140.0% | Added | Holders |
| Q2 2024 | 8,760 | $557.8K | <0.1% | +8,760 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −14,653−100.0% | Sold out | Holders |
| Q1 2022 | 14,653 | $412.0K | <0.1% | −21,286−59.2% | Reduced | Holders |
| Q4 2021 | 35,939 | $1.66M | <0.1% | +18,424+105.2% | Added | Holders |
| Q3 2021 | 17,515 | $575.0K | <0.1% | −7,399−29.7% | Reduced | Holders |
| Q2 2021 | 24,914 | $873.0K | <0.1% | −13,832−35.7% | Reduced | Holders |
| Q1 2021 | 38,746 | $1.40M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.